Hallucinosis on Combined Methyldopa and Pargyline

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hallucinosis following Head Injury

Eleven patients who evinced hallucinations during the early recovery after head injury were studied in detail in comparison to the head injured controls. All of them had suffered from acceleration injuries. Among the clinical variables, post traumatic amnesia was significantly longer in these patients. Length of FTA was found to be correlated with duration of occurrence of hallucinations. Sever...

متن کامل

Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.

ALPHA-METHYLDOPA (a-methyl-3,4-diIA hydroxy-L-phenylalanine [Aldomet]) is a useful antihypertensive agent with sedative and aromatic L-amino decarboxylase-inhibiting properties.'-7 It has several advantages over other potent antihypertensive drugs in current use. Reduction in blood pressure is achieved gradually and occurs in the lying as well as in the standing position. The lack of marked pos...

متن کامل

Thalamic experiential hallucinosis.

Two patients with an infarct limited to the thalamus developed auditory and visual experiential hallucinations. Neuropathological studies in one patient showed a small cavity in the right intralaminar nuclei surrounded by focal spongiform change, partly involving the right dorsomedial nucleus. Neuroradiological data in another patient indicated that the same nuclei in the left thalamus were als...

متن کامل

Hemodynamic Effects of Pargyline in Hypertensive Patients.

T HE use of monoamine oxidase (MAO) inhibitors in the treatment of hypertension has been limited until recently, mainly because the available compounds had a high incidence of accompanying side reactions.' However, the non-hydrazine MAO inhibitor, pargyline, appears to be an effective drug with a relatively low incidence of untoward effects. Clinical studies have substantiated that pargyline is...

متن کامل

Hallucinosis in idiopathic Parkinson's disease.

BACKGROUND Hallucinosis is a complication of the treatment of idiopathic Parkinson's disease commonly thought to afflict older, chronically medicated, cognitively impaired patients. However, patients with idiopathic Parkinson's disease of short duration experiencing hallucinosis on relatively low doses of dopaminergic medication have been found. The aim, therefore, was to investigate the homoge...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 1966

ISSN: 0959-8138,1468-5833

DOI: 10.1136/bmj.1.5490.803-a